Paul Matteis

Stock Analyst at Stifel

(0.83)
# 2308
Out of 5,370 analysts
140
Total ratings
33.93%
Success rate
-4.30%
Average return
41 Stocks
Name Action PT Current % Upside Ratings Updated
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
78 94
62.34 50.79% 2 May 29, 2025
VIGL Vigil Neuroscience
Downgrades: Hold
11 8
7.87 1.65% 2 May 28, 2025
ALNY Alnylam Pharmaceutic...
Maintains: Strong Buy
300 345
308.78 11.73% 13 Mar 31, 2025
NMRA Neumora Therapeutics
Downgrades: Hold
6 2
0.87 129.89% 2 Mar 7, 2025
SION Sionna Therapeutics
Initiates Coverage On: Buy
32
14.25 124.56% 1 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
11
4.63 137.58% 1 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
18 32
12.87 148.64% 2 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
490 494
450.66 9.62% 18 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
12 32
15.11 111.78% 1 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
10 6
9.06 -33.77% 5 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
4
1.5 166.67% 4 Dec 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
32 10
2.31 332.9% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 60
18.88 217.8% 2 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
25 36
29.41 22.41% 7 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
115 87
56.19 54.83% 8 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
41 66
13.81 377.91% 3 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
11.15 213.9% 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
50 53
35.28 50.23% 5 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
26 21
22.12 -5.06% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
4.29 575.99% 1 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
141 144
125.3 14.92% 8 Dec 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
315 287
131.07 118.97% 6 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
3.95 406.33% 1 Nov 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
2.34 412.82% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
24
1.48 1521.62% 2 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
260 295
n/a n/a 4 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
50 54
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
36 5
n/a n/a 2 Jun 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
54 32
13.04 145.4% 1 Jun 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
35
n/a n/a 1 Sep 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
1.14 2268.42% 1 Jul 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 23
n/a n/a 2 Dec 17, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
150 140
n/a n/a 7 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
14
9.48 47.68% 1 Mar 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
60
n/a n/a 6 Nov 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3000 2280
n/a n/a 1 Oct 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
25 31
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 18
n/a n/a 2 Feb 27, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 64
6.84 835.67% 1 Feb 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
28 22
n/a n/a 2 Oct 9, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
340
22.5 1411.11% 1 Dec 21, 2016